July 2014 Pituitary Research Articles
Knowledge is power and we believe keeping abreast of news on the research front is imperative. Each month in Highlights we feature a few of the top news stories, which you can read below. In addition, we update our website on a regular basis with the latest breaking news related to pituitary and hormonal disorders by gathering stories we think you'll be interested in from MD Linx, Medscape, MedPage Today, PubMed, Touch Endocrinology, News-Medical.net and WebMD.
Could different treatment approach in acromegaly influence life expectancy? A comparative study between Bulgaria and Campania (Italy)
European Journal of Endocrinology, 06/16/2014
Cushing's syndrome in a morbidly obese patient undergoing evaluation before bariatric surgery
Obesity Facts 06/16/2014
Medical Treatments for Pituitary Disorders
A comparison of low dose acth, glucagon stimulation and insulin tolerance test in patients with pituitary disorders
Clinical Endocrinology 06/24/2014
FDA: Testosterone Carries VTE Risk
Testosterone products can cause venous thromboembolism (VTE) even in patients without polycythemia, the FDA warned amidst ongoing cardiovascular risk assessment.
Estrogen Alone May Not Suppress Testosterone
CHICAGO -- Simply giving estrogen to male-to-female transgender patients won't completely suppress testosterone levels, researchers reported here.
Puberty Hormone Tied to Premature Ovarian Failure
Kisspeptin hormones may play a key role in premature ovarian failure and in the control of oocyte biology, according to results from animal studies.
Pituitary Tumors – General
Gonadotroph adenoma causing ovarian hyperstimulation syndrome in a premenopausal woman.
Halupczok J, Bidzińska-Speichert B, Lenarcik-Kabza A, Zieliński G, Filus A, Maksymowicz M.
Gynecol Endocrinol. 2014 Jun 27:1-4. [Epub ahead of print]
Specific behaviour, mood and personality traits may contribute to obesity in patients with craniopharyngioma (CP)
Clinical Endocrinology 06/17/2014
ASCO: Androgen Blocker Works in Prostate Ca
CHICAGO -- A drug that blocks the androgen receptor can markedly delay chemotherapy in men with progressive prostate cancer despite androgen-deprivation therapy, a researcher said.
ASCO: Exercise Cuts Cytokines in Prostate Ca
CHICAGO -- A structured physical exercise program appears to reduce cytokine production related to depression and inflammatory processes that may impact prostate cancer progression, researchers said here.
ASCO: Combo Hormone Tx Promising in Prostate Cancer
CHICAGO -- A combination attack on androgens in metastatic prostate cancer resistant to initial hormone therapy drove down testosterone levels and appeared safe, according to a proof of concept study.
Soy Okay in Diabetic Men with Low T
CHICAGO -- Soy supplements won't send testosterone levels plummeting in men with type 2 diabetes who already have low levels of the hormone, researchers reported here.
Children's Endocrine Health
Corneal thickness in children with growth hormone deficiency: The effect of GH treatment
Growth Hormone & IGF Research 06/25/2014
Obstructive Sleep Apnea and Osteoporosis: New Findings
A large population-based cohort study in Taiwan demonstrates an elevated risk of osteoporosis among individuals with obstructive sleep apnea.
BPA Alternative May Still Have Endocrine Effects
CHICAGO -- A plasticizer commonly substituted for bisphenol A (BPA) may cause similar endocrine-disrupting effects as the original chemical, researchers reported here.